TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2220335

Group type: EXPERIMENTAL
Intervention: Orthopantomography
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Transcranial radiography
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Transmaxillary radiography
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Combination of radiographic techniques
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Erosion in the condyle
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Agreement on definite changes in the condyle
Number of subjects: 53
Study: 366350

Group type: EXPERIMENTAL
Intervention: Intranasal beclomethasone dipropionate (300 microgram/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo aerosol
Number of subjects: 22
Study: 31774842

Group type: EXPERIMENTAL
Intervention: Daily educational text messages on diabetes for six months (Intervention)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Intervention group (text messaging)
Number of subjects: 216
Study: 28922519

Group type: EXPERIMENTAL
Intervention: Olive oil treatment
Number of subjects: 831

Group type: COMPARATOR
Intervention: HOFA treatment
Number of subjects: 831
Study: 25569810

Group type: EXPERIMENTAL
Intervention: Adaptive support ventilation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (physician-directed weaning)
Number of subjects: 61
Study: 23418298

Group type: EXPERIMENTAL
Intervention: Procalcitonin-based algorithm for antibiotic therapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard clinical judgement without procalcitonin reference (Control)
Number of subjects: 31
Study: 20502929

Group type: EXPERIMENTAL
Intervention: L. paracasei GMNL‐33
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 19905943

Group type: EXPERIMENTAL
Intervention: Periodontal treatment (scaling and root planing) before 21 weeks of gestation
Number of subjects: 823

Group type: COMPARATOR
Intervention: Control group (periodontal treatment after delivery)
Number of subjects: 823
Study: 17099008

Group type: EXPERIMENTAL
Intervention: High dose all-trans retinoic acid (HD-ATRA) [2 mg/kg/d]
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Low dose all-trans retinoic acid (LD-ATRA) [1 mg/kg/d]
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: 13-cis retinoic acid (13-cRA) [1 mg/kg/d]
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 15577133

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0
Study: 15488343

Group type: EXPERIMENTAL
Intervention: 0.2% sevoflurane in O2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.4% sevoflurane in O2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.6% sevoflurane in O2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.8% sevoflurane in O2
Number of subjects: 20

Group type: COMPARATOR
Intervention: 100% O2 (placebo)
Number of subjects: 20
Study: 10425698

Group type: EXPERIMENTAL
Intervention: HIV risk-reduction intervention
Number of subjects: 496

Group type: COMPARATOR
Intervention: Control intervention on other health issues
Number of subjects: 496
Study: 7990870

Group type: EXPERIMENTAL
Intervention: Bright light exposure
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Bright light exposure with eyes covered
Number of subjects: 17
Study: 2184002

Group type: EXPERIMENTAL
Intervention: Dilevalol
Number of subjects: 0
Study: 7270761

Group type: EXPERIMENTAL
Intervention: Full benefit group (50% copayment)
Number of subjects: 250

Group type: COMPARATOR
Intervention: 50% copayment group
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Both payment groups
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Full benefit group
Number of subjects: 250
Study: 31670008

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT) - twelve 60-s bouts of vibration; frequency 35 Hz; amplitude 4 mm; 1-min rest intervals
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 10
Study: 30569067

Group type: EXPERIMENTAL
Intervention: Native whey (20 g)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: WPC‐80 (20 g)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Milk
Number of subjects: 21
Study: 28356431

Group type: EXPERIMENTAL
Intervention: Peanut meal (3 ounces / 85 g ground peanuts, 1198 kcal)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control meal (matched for energy and macronutrient content)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Peanut meal
Number of subjects: 15
Study: 25929530

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 21
Study: 23172174

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (USG) for CVC placement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anatomic placement (without USG) for CVC placement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (USG) for inadvertent arterial puncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anatomic placement (without USG) for inadvertent arterial puncture
Number of subjects: 0
Study: 21846957

Group type: EXPERIMENTAL
Intervention: Total face mask
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oronasal mask
Number of subjects: 60
Study: 19911216

Group type: EXPERIMENTAL
Intervention: Diet + Dif1stat
Number of subjects: 240

Group type: COMPARATOR
Intervention: Diet
Number of subjects: 240
Study: 17890695

Group type: EXPERIMENTAL
Intervention: Angioplasty (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CABG (Coronary Artery Bypass Grafting)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Registry data
Number of subjects: 0
Study: 15602190

Group type: EXPERIMENTAL
Intervention: Albendazole (15 mg/kg/day twice a day for 7 days)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 200
Study: 11511016

Group type: EXPERIMENTAL
Intervention: Controlled cold therapy (CCT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ice therapy
Number of subjects: 72
Study: 9663245

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography
Number of subjects: 240

Group type: COMPARATOR
Intervention: Intraoperative cholangiography (IOC)
Number of subjects: 240
Study: 8154629

Group type: EXPERIMENTAL
Intervention: Double-blind, placebo-controlled food challenge
Number of subjects: 0

Group type: COMPARATOR
Intervention: Skin prick test (SPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Measurement of specific IgE (RAST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Histamine release from basophils (HR)
Number of subjects: 0
Study: 31734088

Group type: EXPERIMENTAL
Intervention: Photochromic contact lens (Test)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Non-photochromic contact lens (Control)
Number of subjects: 61
Study: 30151504

Group type: EXPERIMENTAL
Intervention: Extract of Salvadora persica miswak
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chlorhexidine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cetylpyridinium
Number of subjects: 100

Group type: COMPARATOR
Intervention: Extract of Azadirachta indica miswak
Number of subjects: 100
Study: 26780085

Group type: EXPERIMENTAL
Intervention: Alendronate treatment
Number of subjects: 639
Study: 24449228

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: SRP and oral doxycycline (100 mg) administration once daily for 15 days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 66
Study: 22563948

Group type: EXPERIMENTAL
Intervention: Felodipin 2.5 mg once daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Low-frequency TENS for 30 min bidaily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Felodipin
Number of subjects: 32

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 32
Study: 20802205

Group type: EXPERIMENTAL
Intervention: Patients with lesions in the anterior corpus callosum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with lesions in the posterior corpus callosum
Number of subjects: 0
Study: 18679411

Group type: EXPERIMENTAL
Intervention: Diet C (increased consumption of cereals, especially breakfast cereals)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Diet V (increased consumption of vegetables)
Number of subjects: 49
Study: 16580190

Group type: EXPERIMENTAL
Intervention: Urokinase (125,000 UI) administered via intrathoracic tube every 12 hours until pleural fluid < 50 cm3
Number of subjects: 29

Group type: COMPARATOR
Intervention: Simple drainage with suction
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Urokinase (125,000 UI) administered via intrathoracic tube
Number of subjects: 29
Study: 12730420

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified beverage containing 11 micronutrients (iron, iodine, zinc, vitamin A, vitamin C, niacin, riboflavin, folate, vitamin B-12, vitamin B-6, and vitamin E) for 8 weeks
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified beverage
Number of subjects: 259
Study: 10784638

Group type: EXPERIMENTAL
Intervention: Dexamethasone 2 mg orally three times a day (tid)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 154
Study: 8729590

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg twice daily, starting at least 2 weeks before PTCA
Number of subjects: 730
Study: 1343609

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (250 mg daily for 6 months)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (80 mg trimethoprim, 400 mg sulfamethoxazole daily for 6 months)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 103

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 103
Study: 4006380

Group type: EXPERIMENTAL
Intervention: Tiapamil 450 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30381582

Group type: EXPERIMENTAL
Intervention: Product A (sun protection factor 50 PA+++)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Product B (sun protection factor 19 PA+++)
Number of subjects: 230
Study: 28488827

Group type: EXPERIMENTAL
Intervention: Water-based exercises
Number of subjects: 132

Group type: COMPARATOR
Intervention: Land-based exercises
Number of subjects: 132
Study: 27825388

Group type: EXPERIMENTAL
Intervention: Exemestane plus ovarian suppression (OFS)
Number of subjects: 1967

Group type: COMPARATOR
Intervention: Tamoxifen plus ovarian suppression (OFS)
Number of subjects: 1967

Group type: EXPERIMENTAL
Intervention: CYP19A1/ESR1 genotypes
Number of subjects: 1967
Study: 25146603

Group type: EXPERIMENTAL
Intervention: ShengJinRunZaoYangXue granules
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 23135126

Group type: EXPERIMENTAL
Intervention: Self-ligating brackets (Damon 3MX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional ligation brackets
Number of subjects: 30
Study: 20229196

Group type: EXPERIMENTAL
Intervention: Tonsillectomy using scissors and raspatory with electrocautery for coagulation (27 patients)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tonsillectomy using pressure‐assisted tissue‐welding technology (33 patients)
Number of subjects: 60
Study: 17094983

Group type: EXPERIMENTAL
Intervention: Daily GnRH agonist (buserelin) administration
Number of subjects: 2

Group type: COMPARATOR
Intervention: Recombinant FSH
Number of subjects: 2

Group type: COMPARATOR
Intervention: hMG
Number of subjects: 2
Study: 15656468

Group type: EXPERIMENTAL
Intervention: Hydrogel dressing
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conservative topical wound-care regimen (gauze with povidone-iodine)
Number of subjects: 27
Study: 11879861

Group type: EXPERIMENTAL
Intervention: Corticosteroid injections
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Wait-and-see policy
Number of subjects: 185
Study: 9527747

Group type: EXPERIMENTAL
Intervention: Low-dose opioid anaesthesia (thoracic epidural analgesia combined with inhalational anaesthesia)
Number of subjects: 16

Group type: COMPARATOR
Intervention: High-dose fentanyl anaesthesia
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both anaesthesia types
Number of subjects: 16
Study: 8527269

Group type: EXPERIMENTAL
Intervention: MK-0591 (50, 125, 250, 500 mg single doses)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MK-0591 (125 mg twice daily for 9.5 days)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MK-0591 (250 mg single dose)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MK-0591 (single dose)
Number of subjects: 50
Study: 2404455

Group type: EXPERIMENTAL
Intervention: Immuno-chemotherapy combined with PSK 3 g/day
Number of subjects: 169

Group type: COMPARATOR
Intervention: Chemotherapy (CDDP 100 mg/m2 day 1, VDS 3 mg/m2 day 1, 8, 15)
Number of subjects: 169
Study: 359024

Group type: EXPERIMENTAL
Intervention: Sulfametopyrazine given once a week over one winter
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 218
Study: 30691519

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 0
Study: 28659234

Group type: EXPERIMENTAL
Intervention: Ginger (250 mg ginger capsules from the onset of menstruation)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Stretching exercises (belly and pelvic stretching exercises for 10 min, 3 times per week)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Stretching exercises
Number of subjects: 122
Study: 25835438

Group type: EXPERIMENTAL
Intervention: High-Intensity Statin Therapy (HIST)
Number of subjects: 3495

Group type: COMPARATOR
Intervention: Low-Intensity Statin Therapy (LIST)
Number of subjects: 3495

Group type: COMPARATOR
Intervention: No-Statin Therapy
Number of subjects: 3495
Study: 25629243

Group type: EXPERIMENTAL
Intervention: Nutrition on the Go strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: PG 3 (low availability of food and medium SEI)
Number of subjects: 0
Study: 21039931

Group type: EXPERIMENTAL
Intervention: Probiotic additive B (Bacillus cereus var. toyoi, 1.6 × 10(6) spores per gram of feed)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Probiotic additive A (Bacillus subtilis and Bacillus licheniformis, 1.6 × 10(6) spores per gram of feed)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (regular corn-soy meal based feed)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Probiotic additive A
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Probiotic additive B
Number of subjects: 120
Study: 19423109

Group type: EXPERIMENTAL
Intervention: Corn oil enriched diet
Number of subjects: 30
Study: 17969367

Group type: EXPERIMENTAL
Intervention: Telmisartan (angiotensin II receptor blocker)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15138463

Group type: EXPERIMENTAL
Intervention: 15 g/day alcohol
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 30 g/day alcohol
Number of subjects: 53

Group type: COMPARATOR
Intervention: 0 g/day alcohol (control)
Number of subjects: 53
Study: 12578244

Group type: EXPERIMENTAL
Intervention: Arm exercises
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Leg exercises
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Arm and leg exercises
Number of subjects: 20
Study: 11477813

Group type: EXPERIMENTAL
Intervention: Purified Xuefu Capsule (PXFC) and western medicine
Number of subjects: 57

Group type: COMPARATOR
Intervention: Western medicine (isosorbide dinitrate, diltiazem or atenolol)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Purified Xuefu Capsule (PXFC)
Number of subjects: 57
Study: 7865804

Group type: EXPERIMENTAL
Intervention: Calculated energy requirements using the Harris Benedict Equation (HBE)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Indirect calorimetry measurements
Number of subjects: 20
Study: 2744969

Group type: EXPERIMENTAL
Intervention: Task condition with cutaneous stimulation on the right hand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task condition with cutaneous stimulation on the left hand
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (attending to electrical pulses)
Number of subjects: 0
Study: 667231

Group type: EXPERIMENTAL
Intervention: Haloperidol (0.5 mg injection)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 12
Study: 29101631

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) for 60 seconds or cord milking (CM)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Early cord clamping (ECC) within 10 seconds
Number of subjects: 215
Study: 27678433

Group type: EXPERIMENTAL
Intervention: Oral-fat tolerance test (OFTT)
Number of subjects: 2117

Group type: EXPERIMENTAL
Intervention: Oral-fat tolerance test (OFTT) in CORDIOPREV study
Number of subjects: 2117

Group type: EXPERIMENTAL
Intervention: Oral-fat tolerance test (OFTT) in GOLDN study
Number of subjects: 2117
Study: 23877305

Group type: EXPERIMENTAL
Intervention: Single shot femoral nerve block (FNB) using 15mL bupivacaine 0.25% and 20 mg clonidine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Single shot femoral nerve block (FNB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard treatment without nerve block (STN)
Number of subjects: 80
Study: 22736302

Group type: EXPERIMENTAL
Intervention: Etravirine (NNRTIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maraviroc (CRAs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK1349572 (INSTIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tenofovir (NtRTIs)
Number of subjects: 0
Study: 20552926

Group type: EXPERIMENTAL
Intervention: Gabapentin (up to 900 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo or lowest dose of gabapentin (300 mg/d)
Number of subjects: 0
Study: 18514114

Group type: EXPERIMENTAL
Intervention: Absorbable sutures
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nonabsorbable sutures
Number of subjects: 50
Study: 16075063

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 0
Study: 12461037

Group type: EXPERIMENTAL
Intervention: Azithromycin administered alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ceftriaxone administered alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Azithromycin and ceftriaxone administered concurrently
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control arm (azithromycin and ceftriaxone administered alone)
Number of subjects: 12
Study: 10656205

Group type: COMPARATOR
Intervention: Calcium (500 mg b.i.d.) and 1000 IU vitamin D3
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Calcium (500 mg b.i.d.) and 1000 IU vitamin D3 with retarded-release sodium fluoride (25 mg t.i.d.)
Number of subjects: 33
Study: 8641119

Group type: EXPERIMENTAL
Intervention: Leucocyte lysates from patients with microalbuminuria
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Leucocyte lysates from patients with proteinuria
Number of subjects: 57

Group type: COMPARATOR
Intervention: Leucocyte lysates from control subjects with normal AER
Number of subjects: 57

Group type: COMPARATOR
Intervention: Leucocyte lysates from NIDDM subjects with normal AER
Number of subjects: 57
Study: 1888048

Group type: COMPARATOR
Intervention: Epidural fentanyl (100 micrograms in 10 ml isotonic saline)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 micrograms in 10 ml isotonic saline) plus epidural clonidine (150 micrograms)
Number of subjects: 20
Study: 6685597

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin + Cigarette smoking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral nicotine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Herbal (nicotine-free) cigarettes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nicotine chewing gum
Number of subjects: 0
Study: 31829266

Group type: EXPERIMENTAL
Intervention: Pragmatic approach to randomised trials
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Flexibility in intervention delivery
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Levels of resourcing and adherence steps
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pragmatic approach to population and trial setting
Number of subjects: 17
Study: 29066122

Group type: EXPERIMENTAL
Intervention: RT + HT (30 Gy in 10 fractions combined with hyperthermia, performed by Thermotron RF‐8, target temperature maintained for 40 minutes, twice weekly for 2 weeks)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: RT + HT
Number of subjects: 57

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 57
Study: 26935286

Group type: EXPERIMENTAL
Intervention: Spacelabs 90217A
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mobil-O-Graph NG
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mercury sphygmomanometer
Number of subjects: 40
Study: 26645514

Group type: EXPERIMENTAL
Intervention: Davaie Loban (DL)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 22651239

Group type: EXPERIMENTAL
Intervention: Triple-site CRT
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional CRT
Number of subjects: 100
Study: 20448860

Group type: EXPERIMENTAL
Intervention: Iontophoresis of 1% Acetylcholine (ACh) with laser Doppler fluximetry (LDF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iontophoresis of 1% Sodium Nitroprusside (SNP) with laser Doppler fluximetry (LDF)
Number of subjects: 0
Study: 18243724

Group type: EXPERIMENTAL
Intervention: Furosemide at 4 mg/h
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline at 2 ml/h (Control)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 42
Study: 16162041

Group type: EXPERIMENTAL
Intervention: Enhanced web site
Number of subjects: 5785

Group type: COMPARATOR
Intervention: Basic web site
Number of subjects: 5785

Group type: EXPERIMENTAL
Intervention: Mailings to principals and directors
Number of subjects: 5785